Indoco Remedies gets USFDA nod to sell generic epilepsy medicine

Indoco Remedies has secured approval from the US health regulator for its generic Lacosamide oral solution. This medication is used to treat epilepsy in adults and children. The approval allows Indoco Remedies to market the drug, which is a generic version of Vimpat Oral Solution. Manufacturing will take place at their Goa facility.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/xR0Qwr2
via IFTTT